The experimental approach employed to generate ROBO1-NK cells and evaluate their anti-tumor efficacy against ROBO1-positive ovarian cancer cells is illustrated in Figure 1A. Initially, immunohistochemistry (IHC) analysis was performed to detect the presence of ROBO1 protein in ovarian cancer tumor tissues obtained from patients. Here, ROBO1 is linked to ovarian cancer.